Skip to main content
Top
Published in: Familial Cancer 3/2018

Open Access 01-07-2018 | Original Article

Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer

Authors: F. G. J. Kallenberg, C. M. Aalfs, F. O. The, C. A. Wientjes, A. C. Depla, M. W. Mundt, P. M. M. Bossuyt, E. Dekker

Published in: Familial Cancer | Issue 3/2018

Login to get access

Abstract

Identifying a hereditary colorectal cancer (CRC) syndrome or familial CRC (FCC) in a CRC patient may enable the patient and relatives to enroll in surveillance protocols. As these individuals are insufficiently recognized, we evaluated an online family history tool, consisting of a patient-administered family history questionnaire and an automated genetic referral recommendation, to facilitate the identification of patients with hereditary CRC or FCC. Between 2015 and 2016, all newly diagnosed CRC patients in five Dutch outpatient clinics, were included in a trial with a stepped-wedge design, when first visiting the clinic. Each hospital continued standard procedures for identifying patients at risk (control strategy) and then, after a predetermined period, switched to offering the family history tool to included patients (intervention strategy). After considering the tool-based recommendation, the health care provider could decide on and arrange the referral. Primary outcome was the relative number of CRC patients who received screening or surveillance recommendations for themselves or relatives because of hereditary CRC or FCC, provided by genetic counseling. The intervention effect was evaluated using a logit-linear model. With the tool, 46/489 (9.4%) patients received a screening or surveillance recommendation, compared to 35/292 (12.0%) in the control group. In the intention-to-treat-analysis, accounting for time trends and hospital effects, this difference was not statistically significant (p = 0.58). A family history tool does not necessarily assist in increasing the number of CRC patients and relatives enrolled in screening or surveillance recommendations for hereditary CRC or FCC. Other interventions should be considered.
Appendix
Available only for authorised users
Literature
2.
go back to reference de Jong AE, Vasen HF (2006) The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med 64(10):367–370PubMed de Jong AE, Vasen HF (2006) The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med 64(10):367–370PubMed
3.
go back to reference Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S (2004) Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2(9):813–819CrossRefPubMed Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S (2004) Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2(9):813–819CrossRefPubMed
4.
go back to reference Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26(35):5783–5788. doi:10.1200/jco.2008.17.5950 CrossRefPubMedPubMedCentral Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26(35):5783–5788. doi:10.​1200/​jco.​2008.​17.​5950 CrossRefPubMedPubMedCentral
5.
go back to reference Dutch Society For Clinical Genetics. CBO Guideline Hereditary Colorectal Cancer 2015 Dutch Society For Clinical Genetics. CBO Guideline Hereditary Colorectal Cancer 2015
6.
go back to reference Dekker N, Hermens RP, Mensenkamp AR, van Zelst-Stams WA, Hoogerbrugge N (2014) Easy-to-use online referral test detects most patients with a high familial risk of colorectal cancer. Colorectal Dis 16(1):O26–O34. doi:10.1111/codi.12407 CrossRefPubMed Dekker N, Hermens RP, Mensenkamp AR, van Zelst-Stams WA, Hoogerbrugge N (2014) Easy-to-use online referral test detects most patients with a high familial risk of colorectal cancer. Colorectal Dis 16(1):O26–O34. doi:10.​1111/​codi.​12407 CrossRefPubMed
7.
go back to reference Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, Lu KH, Roach N, Limburg PJ (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209–217. doi:10.1200/jco.2014.58.1322 CrossRefPubMed Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, Lu KH, Roach N, Limburg PJ (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209–217. doi:10.​1200/​jco.​2014.​58.​1322 CrossRefPubMed
8.
go back to reference Dekker N, Hermens RP, Nagengast FM, van Zelst-Stams WA, Hoogerbrugge N (2013) Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives. Colorectal Dis 15(4):e175-185. doi:10.1111/codi.12117 discussion p.e185.CrossRef Dekker N, Hermens RP, Nagengast FM, van Zelst-Stams WA, Hoogerbrugge N (2013) Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives. Colorectal Dis 15(4):e175-185. doi:10.​1111/​codi.​12117 discussion p.e185.CrossRef
9.
go back to reference van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF, Hereditary Tumor Study Group of the Comprehensive Cancer Centre W (2007) Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 6(1):131–134. doi:10.1007/s10689-006-9114-8 CrossRefPubMedPubMedCentral van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF, Hereditary Tumor Study Group of the Comprehensive Cancer Centre W (2007) Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 6(1):131–134. doi:10.​1007/​s10689-006-9114-8 CrossRefPubMedPubMedCentral
12.
go back to reference Wood ME, Kadlubek P, Pham TH, Wollins DS, Lu KH, Weitzel JN, Neuss MN, Hughes KS (2014) Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol 32(8):824–829. doi:10.1200/jco.2013.51.4661 CrossRefPubMedPubMedCentral Wood ME, Kadlubek P, Pham TH, Wollins DS, Lu KH, Weitzel JN, Neuss MN, Hughes KS (2014) Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol 32(8):824–829. doi:10.​1200/​jco.​2013.​51.​4661 CrossRefPubMedPubMedCentral
13.
go back to reference Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA (2013) Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med 15(12):933–940. doi:10.1038/gim.2013.43 CrossRefPubMed Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA (2013) Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med 15(12):933–940. doi:10.​1038/​gim.​2013.​43 CrossRefPubMed
14.
go back to reference Staal-Rosier PM, Rabeling-Keus IM, Kruyt M (2009) [Inadequate referral for genetic evaluations of patients with colorectal carcinoma]. Ned Tijdschr Geneeskd 153(4):124–128PubMed Staal-Rosier PM, Rabeling-Keus IM, Kruyt M (2009) [Inadequate referral for genetic evaluations of patients with colorectal carcinoma]. Ned Tijdschr Geneeskd 153(4):124–128PubMed
21.
22.
go back to reference Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL (2007) The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 97(4):486–493. doi:10.1038/sj.bjc.6603897 CrossRefPubMedPubMedCentral Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL (2007) The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 97(4):486–493. doi:10.​1038/​sj.​bjc.​6603897 CrossRefPubMedPubMedCentral
23.
go back to reference Lowery JT, Ahnen DJ, Schroy PC 3rd, Baxter Hampel H, Boland N, Burt CR, Butterly RW, Doerr L, Doroshenk M, Feero M, Henrikson WG, Ladabaum N, Lieberman U, McFarland D, Peterson EG, Raymond SK, Samadder M, Syngal NJ, Weber S, Zauber TK, Smith AG R (2016) Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. doi:10.1002/cncr.30080 CrossRefPubMedPubMedCentral Lowery JT, Ahnen DJ, Schroy PC 3rd, Baxter Hampel H, Boland N, Burt CR, Butterly RW, Doerr L, Doroshenk M, Feero M, Henrikson WG, Ladabaum N, Lieberman U, McFarland D, Peterson EG, Raymond SK, Samadder M, Syngal NJ, Weber S, Zauber TK, Smith AG R (2016) Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. doi:10.​1002/​cncr.​30080 CrossRefPubMedPubMedCentral
25.
go back to reference Rubinstein WS, Acheson LS, O’Neill SM, Ruffin MTt, Wang C, Beaumont JL, Rothrock N, Family Healthware Impact Trial G (2011) Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med 13 (11):956–965. doi:10.1097/GIM.0b013e3182241d88 CrossRefPubMedPubMedCentral Rubinstein WS, Acheson LS, O’Neill SM, Ruffin MTt, Wang C, Beaumont JL, Rothrock N, Family Healthware Impact Trial G (2011) Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med 13 (11):956–965. doi:10.​1097/​GIM.​0b013e3182241d88​ CrossRefPubMedPubMedCentral
26.
go back to reference Dekker N, Hermens RP, de Wilt JH, van Zelst-Stams WA, Hoogerbrugge N (2015) Improving recognition and referral of patients with an increased familial risk of colorectal cancer: results from a randomized controlled trial. Colorectal Dis 17(6):499–510. doi:10.1111/codi.12880 CrossRefPubMed Dekker N, Hermens RP, de Wilt JH, van Zelst-Stams WA, Hoogerbrugge N (2015) Improving recognition and referral of patients with an increased familial risk of colorectal cancer: results from a randomized controlled trial. Colorectal Dis 17(6):499–510. doi:10.​1111/​codi.​12880 CrossRefPubMed
28.
go back to reference Chan V, Blazey W, Tegay D, Harper B, Koehler S, Laurent B, Lipka S, Cohn J, Jung MK, Krishnamachari B (2014) Impact of academic affiliation and training on knowledge of hereditary colorectal cancer. Public Health Genomics 17(2):76–83. doi:10.1159/000356938 CrossRefPubMed Chan V, Blazey W, Tegay D, Harper B, Koehler S, Laurent B, Lipka S, Cohn J, Jung MK, Krishnamachari B (2014) Impact of academic affiliation and training on knowledge of hereditary colorectal cancer. Public Health Genomics 17(2):76–83. doi:10.​1159/​000356938 CrossRefPubMed
Metadata
Title
Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer
Authors
F. G. J. Kallenberg
C. M. Aalfs
F. O. The
C. A. Wientjes
A. C. Depla
M. W. Mundt
P. M. M. Bossuyt
E. Dekker
Publication date
01-07-2018
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2018
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-017-0041-7

Other articles of this Issue 3/2018

Familial Cancer 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine